Back
Drug Allergy

Drug Allergy

General drug allergy evaluation including reaction history and risk assessment.

Reaction historyrisk stratificationdelabeling

Overview

Drug allergies are adverse reactions to medications that involve the immune system. They can range from mild skin reactions to life-threatening anaphylaxis. Accurate diagnosis is crucial to avoid unnecessary medication restrictions while ensuring patient safety. Many reported drug allergies are actually adverse drug reactions or intolerances, not true allergies.

types

ige

name

IgE-Mediated (Immediate)

timing

Occurs within minutes to 1-2 hours after exposure

symptoms

  • Hives
  • Swelling
  • Anaphylaxis
  • Bronchospasm

examples

Penicillin, cephalosporins, sulfonamides, NSAIDs

non Ige

name

Non-IgE-Mediated (Delayed)

timing

Occurs hours to days after exposure

symptoms

  • Maculopapular rash
  • Drug reaction with eosinophilia and systemic symptoms (DRESS)
  • Stevens-Johnson syndrome
  • Toxic epidermal necrolysis

examples

Anticonvulsants, allopurinol, sulfonamides

pseudoallergy

name

Pseudoallergic Reactions

mechanism

Non-immune mediated reactions that mimic allergic reactions

examples

Radiocontrast media reactions, NSAID-induced urticaria/angioedema

note

Not true allergies but can be severe

common Culprits

antibiotics

  • Penicillin and related drugs
  • Cephalosporins
  • Sulfonamides
  • Vancomycin

nsaids

Aspirin, ibuprofen, naproxen - can cause urticaria, angioedema, or anaphylaxis

contrast

Radiocontrast media - can cause anaphylactoid reactions

chemotherapy

Various agents can cause hypersensitivity reactions

biologics

Monoclonal antibodies, vaccines - can cause infusion reactions

evaluation

history

  • Detailed reaction history - timing, symptoms, severity
  • Medication name, dose, route of administration
  • Previous exposures and reactions
  • Concurrent medications
  • Underlying medical conditions
  • Family history of drug allergies
  • Documentation in medical records

risk Stratification

high Risk

  • Severe reactions (anaphylaxis, SJS, TEN, DRESS)
  • Recent reaction (< 5 years)
  • Multiple drug allergies
  • Reaction to structurally similar drugs

low Risk

  • Mild, remote reactions (> 10 years ago)
  • Unclear reaction history
  • Symptoms consistent with side effects rather than allergy
  • No reaction on recent exposure

testing

skin

  • Skin prick testing for IgE-mediated reactions
  • Intradermal testing
  • Patch testing for delayed reactions
  • Limited availability for most drugs

ige

Serum-specific IgE testing available for some drugs (penicillin, some cephalosporins)

challenge

  • Graded drug challenge (test dose) - for low-risk patients
  • Drug desensitization - for high-risk patients who need the drug
  • Must be performed in controlled setting with emergency equipment

note

Most drug allergies are diagnosed clinically based on history

management

avoidance

  • Avoid the culprit drug and structurally similar drugs
  • Document clearly in medical records
  • Patient education about drug names and alternatives
  • Medical alert bracelet for severe allergies

alternatives

  • Identify safe alternative medications
  • Consider cross-reactivity patterns
  • Consult with allergist or pharmacist

delabeling

indication

When allergy is unlikely or low-risk, consider delabeling to expand treatment options

process

  • Comprehensive history review
  • Risk assessment
  • Testing if available
  • Graded challenge if appropriate
  • Document removal of allergy label if challenge is negative

benefits

  • Expands treatment options
  • Reduces unnecessary antibiotic restrictions
  • Improves patient outcomes
  • Reduces healthcare costs

desensitization

indication

For patients with confirmed allergy who require the drug

process

Gradually increasing doses under medical supervision

setting

Must be performed in hospital or clinic with emergency equipment

duration

Temporary - patient must continue taking drug regularly to maintain tolerance

penicillin

overview

Penicillin allergy is the most commonly reported drug allergy, but up to 90% of patients are not truly allergic

cross Reactivity

cephalosporins

Low cross-reactivity (< 2%) with modern cephalosporins

carbapenems

Low cross-reactivity

monobactams

No cross-reactivity (aztreonam is safe)

evaluation

Skin testing and challenge protocols available for penicillin allergy evaluation

referral

Refer to allergist for penicillin allergy evaluation and delabeling

documentation

importance

Accurate documentation prevents future medication errors

elements

  • Drug name and class
  • Reaction description and timing
  • Severity
  • Treatment required
  • Date of reaction
  • Testing results if available

when To Refer

  • Unclear diagnosis or reaction history
  • Need for drug that patient reports allergy to
  • Multiple drug allergies limiting treatment options
  • Severe reactions requiring specialized evaluation
  • Penicillin allergy evaluation and delabeling
  • Drug desensitization needed
  • Complex cross-reactivity questions

prognosis

Many drug allergies can be safely delabeled through proper evaluation, expanding treatment options for patients. For confirmed allergies, strict avoidance and identification of safe alternatives is essential. Drug desensitization can allow use of necessary medications in allergic patients when performed under appropriate medical supervision.

Ready to Get Started?

Schedule a consultation to discuss your specific needs and create a personalized treatment plan.